The human lung cellular portfolio, traditionally characterized by cellular morphology and
individual markers, is highly diverse, with over 40 cell types and a complex branching …

Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell
dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed …

Abstract Coronavirus disease 2019 (COVID‐19), a global pandemic caused by the severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has posed a catastrophic threat …

Aging poses a global public health challenge, which is linked to the rise of age-related lung
diseases. The precise understanding of the molecular and genetic changes in the aging …

The development of lung fibrosis is a major concern in patients recovered from severe
COVID-19 pneumonia. This study aimed to document the evolution of diffuse alveolar …

Background Idiopathic pulmonary fibrosis (IPF) has attracted considerable attention
worldwide and is challenging to diagnose. Cuproptosis is a new form of cell death that …

Abstract Background The Multi-System Inflammatory Syndrome in Children (MIS-C) can
develop several weeks after SARS-CoV-2 infection and requires a distinct treatment …

Abstract Background Interstitial lung diseases (ILDs) are a diverse group of conditions
characterized by inflammation and fibrosis in the lung. In some patients with ILD, a …

Acute respiratory distress syndrome (ARDS) is a serious inflammatory lung disorder and a
complication of SARS-CoV-2 infection. In patients with severe SARS-CoV-2 infection, the …

Although recent decades have seen the identification, classification and discovery of the
genetic basis of many children's interstitial and rare lung disease (chILD) disorders, detailed …